{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:02:57Z","timestamp":1767848577991,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ejmech.2013.10.071","type":"journal-article","created":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T16:45:36Z","timestamp":1383929136000},"page":"105-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors"],"prefix":"10.1016","volume":"71","author":[{"given":"Laura","family":"De Luca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca M.","family":"Damiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Vullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Chimirri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosaria","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2013.10.071_bib1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10025","article-title":"Carbonic anhydrase inhibitors","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2013.10.071_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/cr050262p","article-title":"Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding","volume":"108","author":"Krishnamurthy","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2013.10.071_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2013.10.071_bib4","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.2174\/138161210793429797","article-title":"Carbonic anhydrase inhibition\/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets","volume":"16","author":"Supuran","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2013.10.071_bib5","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.10.071_bib6","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.2174\/138161210793429779","article-title":"Carbonic anhydrases: again, and again, and again","volume":"16","author":"Supuran","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2013.10.071_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/138161208783877947","article-title":"Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2013.10.071_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/14728214.13.2.383","article-title":"Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity","volume":"13","author":"Supuran","year":"2008","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.ejmech.2013.10.071_bib9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2174\/156802607780636762","article-title":"Antiobesity carbonic anhydrase inhibitors","volume":"7","author":"De Simone","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/156802607780636726","article-title":"Carbonic anhydrase inhibitors as anticonvulsant agents","volume":"7","author":"Thiry","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib11","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1021\/jm701526d","article-title":"Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs","volume":"51","author":"Thiry","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2013.06.003","article-title":"Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity","volume":"66C","author":"Suthar","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/13543776.2013.782394","article-title":"Anticonvulsant\/antiepileptic carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Aggarwal","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2013.10.071_bib14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/jm3015348","article-title":"Synthesis and SAR of novel Re\/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia","volume":"56","author":"Lu","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/138161208783877848","article-title":"Design of zinc binding functions for carbonic anhydrase inhibitors","volume":"14","author":"Winum","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2013.10.071_bib16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/med.20068","article-title":"Therapeutic potential of sulfamides as enzyme inhibitors","volume":"26","author":"Winum","year":"2006","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2013.10.071_bib17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0888-7543(91)90006-Z","article-title":"Characterization of the human gene for a newly discovered carbonic anhydrase, CA VII, and its localization to chromosome 16","volume":"11","author":"Montgomery","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.ejmech.2013.10.071_bib18","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.bmcl.2011.12.134","article-title":"Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors","volume":"22","author":"Truppo","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.10.071_bib19","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.biochi.2010.05.008","article-title":"Analysis of a shortened form of human carbonic anhydrase VII expressed in\u00a0vitro compared to the full-length enzyme","volume":"92","author":"Bootorabi","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2013.10.071_bib20","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/cmdc.200700057","article-title":"Exploration of the binding mode of indanesulfonamides as selective inhibitors of human carbonic anhydrase type VII by targeting Lys 91","volume":"2","author":"Thiry","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2013.10.071_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pain.2009.11.015","article-title":"Acetazolamide and midazolam act synergistically to inhibit neuropathic pain","volume":"148","author":"Asiedu","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2013.10.071_bib22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/cmdc.201000044","article-title":"Identification of potent and selective human carbonic anhydrase VII (hCA VII) inhibitors","volume":"5","author":"Gitto","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2013.10.071_bib23","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.bmcl.2010.07.051","article-title":"Crystal structure of the C183S\/C217S mutant of human CA VII in complex with acetazolamide","volume":"20","author":"Di Fiore","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.10.071_bib24","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/jm2000213","article-title":"Structural basis for the interaction between carbonic anhydrase and 1,2,3,4-tetrahydroisoquinolin-2-ylsulfonamides","volume":"54","author":"Mader","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib25","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1021\/jm300818k","article-title":"Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups","volume":"55","author":"D'Ambrosio","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib26","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1021\/jm9014026","article-title":"Identification of 3,4-dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme-ligand X-ray studies","volume":"53","author":"Gitto","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib27","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/jm300112w","article-title":"Synthesis, structure\u2013activity relationship studies, and X-ray crystallographic analysis of arylsulfonamides as potent carbonic anhydrase inhibitors","volume":"55","author":"Gitto","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2012.02.050","article-title":"Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases","volume":"51","author":"Capkauskaite","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib29","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1016\/j.bmc.2010.09.016","article-title":"Indapamide-like benzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, and XIII","volume":"18","author":"Capkauskaite","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib30","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.bmc.2013.01.008","article-title":"4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII","volume":"21","author":"Dudutiene","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2013.04.035","article-title":"Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis","volume":"66C","author":"Wang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejmech.2013.01.030","article-title":"Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship","volume":"62","author":"Gao","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib33","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1016\/j.bmc.2007.04.020","article-title":"Carbonic anhydrases as targets for medicinal chemistry","volume":"15","author":"Supuran","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib34","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1016\/j.bmc.2009.03.066","article-title":"Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides","volume":"17","author":"Gitto","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib35","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1016\/j.bmc.2011.10.015","article-title":"Synthesis and biological profile of new 1,2,3,4-tetrahydroisoquinolines as\u00a0selective carbonic anhydrase inhibitors","volume":"19","author":"Gitto","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib36","unstructured":"Catalyst (Version 4.10), Accelrys Inc., San Diego, CA (USA), 2005, http:\/\/www.accelrys.com."},{"key":"10.1016\/j.ejmech.2013.10.071_bib37","unstructured":"Discovery Studio (Version 2.5), Accelrys Inc., San Diego, CA (USA), 2009, http:\/\/www.accelrys.com."},{"key":"10.1016\/j.ejmech.2013.10.071_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1093-3263(02)00123-7","article-title":"VEGA: a versatile program to convert, handle and visualize molecular structure on windows-based PCs","volume":"21","author":"Pedretti","year":"2002","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2013.10.071_bib39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2013.10.071_bib40","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1016\/j.bmcl.2005.06.055","article-title":"Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides","volume":"15","author":"Nishimori","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.10.071_bib41","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1021\/jm050483n","article-title":"Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors","volume":"48","author":"Nishimori","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib42","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.bmcl.2006.12.113","article-title":"Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions","volume":"17","author":"Innocenti","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.10.071_bib43","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1021\/jm0512600","article-title":"Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs","volume":"49","author":"Nishimori","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.071_bib44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2013.10.071_bib45","unstructured":"W.L. DeLano, The PyMOL Molecular Graphics System, DeLano Scientific LLC, San Carlos, CA, USA, 2002, http:\/\/www.pymol.org."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413007228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413007228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T19:27:00Z","timestamp":1539199620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523413007228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":45,"alternative-id":["S0223523413007228"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.10.071","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.10.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}